Leland Metheny, MD
Case Comprehensive Cancer Center, University Hospitals Cleveland Medical Center · University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center · University Hospitals Seidman Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Leland Metheny, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:39 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06904482 · Co-Transplant of an Unmodified Haplo-Identical Graft With Cord BloodCase Comprehensive Cancer Center · recruiting · aGVHD, Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia · principal investigator
- Ph2NCT06680661 · ABBA CORD: dCBT w/ Abatacept for aGVHD ProphylaxisLeland Metheny · suspended · Acute Myelogenous Leukemia, Acute Lymphatic Leukemia, Chronic Myelogenous Leukemia · principal investigator
- Ph1NCT05546723 · LMY-920 for Treatment of Relapsed or Refractory MyelomaLuminary Therapeutics · unknown · Multiple Myeloma, Refractory, Multiple Myeloma in Relapse · principal investigator
- Ph2NCT05052957 · hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)Leland Metheny · recruiting · Glioblastoma Multiforme, Glioblastoma Multiforme, Adult, Supratentorial Glioblastoma · principal investigator
- Ph2NCT04059757 · Fecal Microbiota Transplantation For The Treatment Of Gastro-Intestinal Acute GVHDLeland Metheny · withdrawn · Gastro-Intestinal Acute Graft Versus Host Disease (GI-aGVHD) · principal investigator
- Ph1NCT03939585 · Preemptive Infusion of Donor Lymphocytes Depleted of TCR + T Cells + CD19+ B Cells Following ASCTLeland Metheny · withdrawn · Allogeneic Stem Cell Transplant Candidate, Acute Myeloid/Lymphoblastic Leukemia, Myelodysplastic Syndrome · principal investigator
- Ph2NCT03342196 · Thiotepa Plus Fludarabine+ Melphalan as the Preparative Regime for Alternative Donor TransplantationCase Comprehensive Cancer Center · completed · Leukemia · principal investigator
- Ph1/Ph2NCT03104491 · Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic LeukemiaLeland Metheny · recruiting · Acute Lymphocytic Leukemia · principal investigator
- Early Ph1NCT02181478 · Intra-Osseous Co-Transplant of UCB and hMSCCase Comprehensive Cancer Center · completed · Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndromes · principal investigator
- N/ANCT02158767 · Access Protocol. Infusion of CD34+ Enriched, T Cell Depleted Hematopoietic Stem Cell Grafts.Leland Metheny · no longer available · Hematopoietic/Lymphoid Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:39 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Chemoprotection & Immune Remodeling after Hematopoietic Progenitor Cell Gene Therapy for GlioblastomaU01CA236215 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI STANTON L. GERSON · fiscal years 2019 to 2022Named on NCT05052957
- Imaging ResearchP30CA043703 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI Christopher A Flask · fiscal years 2009 to 2026Named on NCT02181478
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in chronic myeloid leukemia.